Related Experiment Video
Updated: Mar 25, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Chronic Subdural Hematoma in the Aged, Trauma or Degeneration?
1Department of Neurosurgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
Insights
Chronic subdural hematomas (CSHs) are often linked to trauma but require sufficient subdural space, typically due to brain atrophy from aging. Degeneration, not just injury, plays a key role in CSH development in older individuals.
Area of Science:
- Neurology
- Neurosurgery
- Geriatrics
Background:
- Chronic subdural hematomas (CSHs) are traditionally viewed as traumatic brain injuries.
- Historical perspectives classify CSHs as stroke or inflammatory diseases before the 20th century.
- CSH development is contingent on adequate subdural space, irrespective of trauma severity.
Purpose of the Study:
- To investigate the etiological trends of chronic subdural hematomas (CSHs).
- To propose an alternative perspective on CSH causation based on literature review.
- To elucidate the pivotal role of brain atrophy in CSH development.
Main Methods:
- Comprehensive literature review on chronic subdural hematoma (CSH) etiology.
- Analysis of historical and current understandings of CSH pathogenesis.
- Identification of key determinants for CSH formation.
Main Results:
- CSHs often originate from subdural hygromas or acute subdural hematomas.
- Neomembrane formation and capillary proliferation are crucial steps in CSH development.
- Sufficient subdural space, primarily caused by age-related brain atrophy, is the key determinant for CSH formation, even without significant trauma.
Conclusions:
- Trauma or bleeding diathesis can precipitate CSH but are not sole causes.
- Brain degeneration, particularly aging-induced atrophy, is a primary factor in CSH development.
- CSHs in the elderly are significantly influenced by brain degeneration, challenging the purely traumatic etiology.
Abstract:
Chronic subdural hematomas (CSHs) are generally regarded to be a traumatic lesion. It was regarded as a stroke in 17th century, an inflammatory disease in 19th century. From 20th century, it became a traumatic lesion. CSH frequently occur after a trauma, however, it cannot occur when there is no enough subdural space even after a severe head injury. CSH may occur without trauma, when there is sufficient subdural space. The author tried to investigate trends in the causation of CSH. By a review of literature, the author suggested a different view on the causation of CSH. CSH usually originated from either a subdural hygroma or an acute subdural hematoma. Development of CSH starts from the separation of the dural border cell (DBC) layer, which induces proliferation of DBCs with production of neomembrane. Capillaries will follow along the neomembrane. Hemorrhage would occur into the subdural fluid either by tearing of bridge veins or repeated microhemorrhage from the neomembrane. That is the mechanism of hematoma enlargement. Trauma or bleeding tendency may precipitate development of CSH, however, it cannot lead CSH, if there is no sufficient subdural space. The key determinant for development of CSH is a sufficient subdural space, in other words, brain atrophy. The most common and universal cause of brain atrophy is the aging. Modifying Virchow's description, CSH is sometimes traumatic, but most often caused by degeneration of the brain. Now, it is reasonable that degeneration of brain might play pivotal role in development of CSH in the aged persons.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
09:49Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacodynamics in Geriatric Patients: Effects of Age
Dementia
The progression of dementia is generally gradual....
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution